In focus · trending topic

Robert Ritch

2 stories · following the connections

AXIM Biotech Retains Ora to Manage Upcoming Product Development and Clinical Trials on Glaucoma and Dry Eye Indications

By Nasdaq OMXMar 21, 2017, 1:01 PM UTC

AXIM Biotech Retains Ora to Manage Upcoming Product Development and Clinical Trials on Glaucoma and Dry Eye Indications

By Nasdaq OMXMar 21, 2017, 1:01 PM UTC